MORGAN STANLEY

Position in GPCR — Structure Therapeutics Inc.

CIK 895421 NEW YORK, NY

Position in GPCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$111,123,024

-$34,085,826 QoQ

Shares Held

2,305,457

+10.4% QoQ

Ownership

1.08%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. GPCR ranks #26 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$111,123,024	2,305,457	+10.4%	Shares	Defined	2026-05-15
2025-12-31	$145,208,850	2,087,834	+261.4%	Shares	Defined	2026-05-27
2025-09-30	$16,176,748	577,741	-37.0%	Shares	Defined	2026-05-27
2025-06-30	$19,025,751	917,346	+32.5%	Shares	Defined	2025-08-15
2025-03-31	$11,986,115	692,439	+78.8%	Shares	Defined	2025-05-15
2024-12-31	$10,500,210	387,176	+138.3%	Shares	Defined	2025-05-15
2024-09-30	$7,131,507	162,486	+22.8%	Shares	Defined	2025-05-14
2024-06-30	$5,195,066	132,291	-54.9%	Shares	Defined	2025-05-14
2024-03-31	$12,585,107	293,633	+2.3%	Shares	Defined	2024-10-17
2023-12-31	$11,700,929	287,069	+1105.5%	Shares	Defined	2024-08-16
2023-09-30	$1,200,700	23,814	+216390.9%	Shares	Defined	2023-11-15
2023-03-31	$261	11	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.